June 23, 2018, Saturday
Biocon said that it is committed to global standards of quality and compliance in a BSE filing after receiving the Establishment Inspection ...
June 22, 2018, Friday
The stock was up 5% to Rs 1,416 after the company said it has received approval from the Drug Controller General of India to market Durvalumab, ...
June 21, 2018, Thursday
Synergy benefits from acquisition of Unichem's products may raise earnings
June 21, 2018, Thursday
The drug maker has guided for an increase in R&D expenses in FY 19 as it builds a pipeline of specialty products
June 20, 2018, Wednesday
Thus far in the calendar year 2018, the stock of this pharmaceutical company has zoomed 107% from Rs 1,289, as compared to 4% rise in the S&P ...
June 20, 2018, Wednesday
The stock up 3% at Rs 622 on the BSE in early morning trade and is 6.6% away from its 52-week high of Rs 663 touched on November 7, 2017.
June 19, 2018, Tuesday
Market size of drug is $40 mn. Having a manufacturing footprint in the US is part of company's game plan to mitigate regulatory risk
June 19, 2018, Tuesday
The drug has been approved by the US Food and Drug Administration
June 17, 2018, Sunday
The court has scheduled an expedited hearing of the preliminary injection for Thursday (June 28) and a ruling is expected soon after
June 16, 2018, Saturday
Dr Reddy's recently announced the launch of Buprenophine and Naloxone Sublingual Film, a generic equivalent of Suboxone
June 15, 2018, Friday
FHL informed BSE in a filing, that its board has decided to withdraw the 'arrangement and amalgamation between the company, Fortis Malar ...
June 15, 2018, Friday
Mylan Technologies Inc too has received the FDA nod for the same drug Suboxone (buprenorphine and naloxone) sublingual film in multiple ...
June 15, 2018, Friday
At 11:23 am; Nifty Pharma index, the largest gainer among sectoral indices, was up 2.2% at 9,310, surging 8.2% thus far in current week.
June 15, 2018, Friday
In past eight trading sessions, the stock of pharmaceutical company has rallied 20% from Rs 1,960 on June 5, 2018, as compared to 2% rise in the ...
June 14, 2018, Thursday
The Fortis Malar stock reacted positively to the decision and the scrip closed at Rs 51.85 a share
June 14, 2018, Thursday
At 03:16 pm; the Nifty Pharma index, the sole gainer among sectoral indices, was up 2%, as compared to 0.49% decline in Nifty 50 index.
June 14, 2018, Thursday
The scheme is currently pending for approval with the National Company Law Tribunal (NCLT), Chandigarh bench
June 14, 2018, Thursday
The stock has moved higher by 8% to Rs 530, bouncing back 11% from early morning low of Rs 478 on the BSE.
June 14, 2018, Thursday
Fortis Healthcare had posted weak fourth-quarter numbers, two bidders said. The company will declare results on June 25
June 13, 2018, Wednesday
The stock was up 4% to Rs 561 on BSE in early morning trade, extending its past five days 14% rally, after the company announced the resolution ...
June 13, 2018, Wednesday
Analysts at Nomura believe there is a strong probability that the company will get approval in the near term for Suboxone & expect initially ...
June 12, 2018, Tuesday
While the plant was served warning letter by US regulator in December 2015, product approvals were frozen in September 2014
June 12, 2018, Tuesday
Marksans Pharma, Alembic Pharma, Caplin Point Lab, Ajanta Pharma, Bliss GVS Pharma, Granules India, Aurobindo Pharma and Wockhardt were up in ...
June 12, 2018, Tuesday
In May, price growth for drugs was in negative territory at (-)1 per cent
June 12, 2018, Tuesday
The hospital chain's board postponed the result to consider the findings of an investigation report into controversial related party ...
June 11, 2018, Monday
The approval is for strengths of 75 mg and 100 mg
June 11, 2018, Monday
The stock is locked in upper circuit of 20% at Rs 522 after the company received approval from the USFDA for its ANDA Bupropion hydrochloride ...
June 08, 2018, Friday
Sun Pharma, Cadila Healthcare, Dr Reddy's Laboratories, Cipla, Glenmark Pharma and Lupin from the Nifty Pharma index were up in the range of 2% ...
June 08, 2018, Friday
The partner is likely to have the rights for the drug in the US, the EU and Japan markets and help with the approvals from the regulators in ...
June 07, 2018, Thursday
The stock, which has been trending down due to weak sentiment towards the pharma sector, could provide a good opportunity for investors at ...
June 06, 2018, Wednesday
Analysts expect Biocon to gain 20-25 per cent market share and after factoring in a 20-25 per cent price erosion in the first year, they see its ...
June 05, 2018, Tuesday
Advanced Enzyme, IL&FS Transportation Networks, Inox Wind, Narayana Hrudayalaya and Navkar Corporation were among 9 stocks from the S&P BSE500 ...
June 05, 2018, Tuesday
The stock hit a record high of Rs 695, up 6% on the BSE in opening deal in otherwise weak market.
June 04, 2018, Monday
Lupin's product is the generic equivalent of Novartis Pharmaceuticals Corp's Methergine
June 04, 2018, Monday
The stock was up nearly 4% to Rs 2,010 on the BSE in early morning trade after the company said the US health regulator has completed the audit ...
June 04, 2018, Monday
Double-digit sales growth, operating margin at 16-quarter lows
June 01, 2018, Friday
All the four selected entities had participated in previous investment process.
June 01, 2018, Friday
Fortis said it has received interest from various parties on May 31, as per the timeline specified in the fresh process for bidding
June 01, 2018, Friday
The company is bullish about the prospects of its Africa generic business
June 01, 2018, Friday
Any regulatory action, however, could offset gains from operational improvement
May 31, 2018, Thursday
If this is all that comes out of Allergan's strategic review, it won't be enough to satisfy angry investors and possible activists
